Fig. 2.

Pre-dose and 2 h post-dose resting inspiratory capacity at Week 3 – adjusted mean differences between treatments (intention-to-treat set). Mean (SD) baseline values were 2.450 (0.693), 2.548 (0.712) and 2.540 (0.733) L for BDP/FF/G, BDP/FF and placebo, respectively. Pre-dose data available from 92, 93 and 93 patients with BDP/FF/G, BDP/FF and placebo, respectively; post-dose data available from 91, 91 and 89 patients, respectively. BDP, beclometasone dipropionate; FF, formoterol fumarate; G, glycopyrronium. The comparisons between BDP/FF/G and BDP/FF (i.e., the last row of the figure) are exploratory endpoints